[go: up one dir, main page]

Seya et al., 1985 - Google Patents

Generation of C3d, g and C3d by urokinase-treated plasma in association with fibrinolysis

Seya et al., 1985

Document ID
14649453477343456725
Author
Seya T
Nagasawa S
Matsukura M
Hasegawa H
Atkinson J
Publication year
Publication venue
Complement

External Links

Snippet

In the breakdown of fluid phase C3 in plasma, the process of conversion of iC3b to C3c and 'C3d'has not been elucidated. Using fluorescent labeled iC3b as a substrate, urokinase (UK) treated but not normal plasma was found to exhibit effective 'C3d'production. To address the …
Continue reading at karger.com (other versions)

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing

Similar Documents

Publication Publication Date Title
Bouma et al. Human blood coagulation factor XI. Purification, properties, and mechanism of activation by activated factor XII.
Katayama et al. Comparison of amino acid sequence of bovine coagulation Factor IX (Christmas Factor) with that of other vitamin K-dependent plasma proteins.
Lijnen et al. Isolation and characterization of a human plasma protein with affinity for the lysine binding sites in plasminogen. Role in the regulation of fibrinolysis and identification as histidine-rich glycoprotein.
Lu et al. Comparison of activated protein C/protein S-mediated inactivation of human factor VIII and factor V
Fair et al. Combined functional and immunochemical analysis of normal and abnormal human factor X
Bilezikian et al. Unique pattern of fibrinogen cleavage by human leukocyte proteases
Esmon et al. The conversion of prothrombin to thrombin: II. Differentiation between thrombin-and factor Xa-catalyzed proteolyses
Morita et al. Preparation and properties of derivatives of bovine factor X and factor Xa from which the gamma-carboxyglutamic acid containing domain has been removed.
Berkowitz et al. Epitope mapping of the von Willebrand factor subunit distinguishes fragments present in normal and type IIA von Willebrand disease from those generated by plasmin.
Civello et al. Substrate specificity of a hemorrhagic proteinase from timber rattlesnake venom
Suzuki Activated protein C inhibitor
JP2008289498A (en) Purified multimerase
Movat The plasma kallikrein-kinin system and its interrelationship with other components of blood
Caughey Roles of mast cell tryptase and chymase in airway function
Remold et al. Enhancement of migration inhibitory factor activity by plasma esterase inhibitors
JPH09221432A (en) Medicine preparation containing von willebrand's factor
Seya et al. Generation of C3d, g and C3d by urokinase-treated plasma in association with fibrinolysis
JPH08506181A (en) Novel anticoagulant cofactor activity
Machovich et al. Denatured proteins as cofactors for plasminogen activation
Komori et al. Effect of bilineobin, a thrombin-like proteinase from the venom of common cantil (Agkistrodon bilineatus)
Seale et al. Tridegin, a novel peptidic inhibitor of factor XIIIa from the leech, Haementeria ghilianii, enhances fibrinolysis in vitro
Ferguson et al. Localization of the disulfide bond in human antithrombin III required for heparin-accelerated thrombin inactivation
Doolittle Searching for differences between fibrinogen and fibrin that affect the initiation of fibrinolysis
Torres et al. Bmoo FIBMP‐I: A New Fibrinogenolytic Metalloproteinase from Bothrops moojeni Snake Venom
EP0239644A1 (en) Novel physiologically active substance having blood coagulation controlling activity